STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
STAT News · LC · trust 34/100
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
Read the original at STAT News →
Open in TruthVane →